Cite

HARVARD Citation

    Pugliese, D. et al. (2021). Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study. United European Gastroenterology journal. 9 (1), pp. 102-109. [Online]. 
  
Back to record